1. Ebstein RP, Benjamin J, Belmaker RH. Personality and polymorphisms of genes involved in aminergic neurotransmission. Eur J Pharmacol 2000;410:205-214. PMID:
11134670.
2. Kusumi I, Masui T, Kakiuchi C, Suzuki K, Akimoto T, Hashimoto R, et al. Relationship between XBP1 genotype and personality traits assessed by TCI and NEO-FFI. Neurosci Lett 2005;391:7-10. PMID:
16154272.
3. Bouchard TJ Jr. Genes, environment, and personality. Science 1994;264:1700-1701. PMID:
8209250.
4. Huang XL, Zou YS, Maher TA, Newton S, Milunsky JM. A de novo balanced translocation breakpoint truncating the autism susceptibility candidate 2 (AUTS2) gene in a patient with autism. Am J Med Genet A 2010;152A:2112-2114. PMID:
20635338.
5. Ben-David E, Granot-Hershkovitz E, Monderer-Rothkoff G, Lerer E, Levi S, Yaari M, et al. Identification of a functional rare variant in autism using genome-wide screen for monoallelic expression. Hum Mol Genet 2011;20:3632-3641. PMID:
21680558.
6. Elia J, Gai X, Xie HM, Perin JC, Geiger E, Glessner JT, et al. Rare structural variants found in attention-deficit hyperactivity disorder are preferentially associated with neurodevelopmental genes. Mol Psychiatry 2010;15:637-646. PMID:
19546859.
7. McCarthy SE, Gillis J, Kramer M, Lihm J, Yoon S, Berstein Y, et al. De novo mutations in schizophrenia implicate chromatin remodeling and support a genetic overlap with autism and intellectual disability. Mol Psychiatry 2014;19:652-658. PMID:
24776741.
8. Hattori E, Toyota T, Ishitsuka Y, Iwayama Y, Yamada K, Ujike H, et al. Preliminary genome-wide association study of bipolar disorder in the Japanese population. Am J Med Genet B Neuropsychiatr Genet 2009;150B:1110-1117. PMID:
19259986.
9. Hori K, Nagai T, Shan W, Sakamoto A, Taya S, Hashimoto R, et al. Cytoskeletal regulation by AUTS2 in neuronal migration and neuritogenesis. Cell Rep 2014;9:2166-2179. PMID:
25533347.
10. Zhang B, Xu YH, Wei SG, Zhang HB, Fu DK, Feng ZF, et al. Association study identifying a new susceptibility gene (AUTS2) for schizophrenia. Int J Mol Sci 2014;15:19406-19416. PMID:
25347278.
11. Chen YH, Liao DL, Lai CH, Chen CH. Genetic analysis of AUTS2 as a susceptibility gene of heroin dependence. Drug Alcohol Depend 2013;128:238-242. PMID:
22995765.
12. Dang W, Zhang Q, Zhu YS, Lu XY. The evidence for the contribution of the autism susceptibility candidate 2 (AUTS2) gene in heroin dependence susceptibility. J Mol Neurosci 2014;54:811-819. PMID:
25398668.
13. Chojnicka I, Gajos K, Strawa K, Broda G, Fudalej S, Fudalej M, et al. Possible association between suicide committed under influence of ethanol and a variant in the AUTS2 gene. PLoS One 2013;8:e57199. PMID:
23437340.
14. Schumann G, Coin LJ, Lourdusamy A, Charoen P, Berger KH, Stacey D, et al. Genome-wide association and genetic functional studies identify autism susceptibility candidate 2 gene (AUTS2) in the regulation of alcohol consumption. Proc Natl AcadSci U S A 2011;108:7119-7124.
15. Cloninger CR. A unified biosocial theory of personality and its role in the development of anxiety states. Psychiatr Dev 1986;4:167-226. PMID:
3809156.
16. Cloninger CR, Svrakic DM, Przybeck TR. A psychobiological model of temperament and character. Arch Gen Psychiatry 1993;50:975-990. PMID:
8250684.
17. Narita S, Nagahori K, Nishizawa D, Yoshihara E, Kawai A, Ikeda K, et al. Association between AUTS2 haplotypes and alcohol dependence in a Japanese population. Acta Neuropsychiatr 2016;28:214-220. PMID:
26763194.
18. Kijima N, Saito R, Takeuchi M, Yoshino A, Ono Y, Kato M, et al. Cloninger’s seven-factor model of temperament and character and Japanese version of Temperament and Character Inventory (TCI). Jpn J Psychiatr Diagn 1996;7:379-399.
19. O’Neil MK, Mingie P. Life stress and depression in university students: clinical illustrations of recent research. J Am Coll Health 1988;36:235240
20. Spitzer RL, Kroenke K, Williams JB. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 1999;282:1737-1744. PMID:
10568646.
21. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001;16:606-613. PMID:
11556941.
22. Kroenke K, Spitzer RL. The PHQ-9: a new depression diagnostic andseverity measure. Psychiatr Ann 2002;32:509-521.
23. Muramatsu K, Miyaoka H, Kamijima K, Muramatsu Y, Yoshida M, Otsubo T, et al. The patient health questionnaire, Japanese version: validity according to the mini-international neuropsychiatric interview-plus. Psychol Rep 2007;101:952-960. PMID:
18232454.
24. Arroll B, Goodyear-Smith F, Crengle S, Gunn J, Kerse N, Fishman T, et al. Validation of PHQ-2 and PHQ-9 to screen for major depression in the primary care population. Ann Fam Med 2010;8:348-353. PMID:
20644190.
25. Inagaki M, Ohtsuki T, Yonemoto N, Kawashima Y, Saitoh A, Oikawa Y, et al. Validity of the Patient Health Questionnaire (PHQ)-9 and PHQ-2 in general internal medicine primary care at a Japanese rural hospital: a cross-sectional study. Gen Hosp Psychiatry 2013;35:592-597. PMID:
24029431.
26. Barrett JC, Fry B, Maller J, Daly MJ. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 2005;21:263-265. PMID:
15297300.
27. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and populationbased linkage analyses. Am J Hum Genet 2007;81:559-575. PMID:
17701901.
28. Oksenberg N, Ahituv N. The role of AUTS2 in neurodevelopment and human evolution. Trends Genet 2013;29:600-608. PMID:
24008202.
29. Myung W, Kim J, Lim SW, Shim S, Won HH, Kim S, et al. A genomewide association study of antidepressant response in Koreans. Transl Psychiatry 2015;5:e633. PMID:
26348319.
30. Cloninger CR. A systematic method for clinical description and classification of personality variants. A proposal. Arch Gen Psychiatry 1987;44:573-588. PMID:
3579504.
31. Mattick JS, Gagen MJ. The evolution of controlled multitasked gene networks: the role of introns and other noncoding RNAs in the development of complex organisms. Mol Biol Evol 2001;18:1611-1630. PMID:
11504843.
32. Cohen J. A power primer. Psychol Bull 1992;112:155-159. PMID:
19565683.
33. Tsai SJ, Wang YC, Hong CJ. Norepinephrine transporter and alpha (2c) adrenoceptor allelic variants and personality factors. Am J Med Genet 2002;114:649-651. PMID:
12210281.
34. Muramatsu K, Miyaoka H, Kamijima K, Muramatsu Y. The patient health questionnaire (PHQ)-9: a depression diagnostic and severity measure in primary care. Jpn J Psychiatr Treat 2008;23:1299-1306.
35. Löwe B, Spitzer RL, Gräfe K, Kroenke K, Quenter A, Zipfel S, et al. Comparative validity of three screening questionnaires for DSM-IV depressive disorders and physicians’ diagnoses. J Affect Disord 2004;78:131-140. PMID:
14706723.